Skip to main content
Erschienen in: European Journal of Nutrition 6/2007

01.09.2007 | ORIGINAL CONTRIBUTION

Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology

verfasst von: Michelle Finney, Joanne Smullen, Howard A. Foster, Saskia Brokx, Prof. David M. Storey

Erschienen in: European Journal of Nutrition | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Lactitol (4-β-d-galactopyranosyl-d-glucitol) is a sugar alcohol used as a sweetener. Previous studies have shown that it has a beneficial effect on intestinal microflora.

Aims of the study

To determine whether low doses of lactitol had beneficial effects without eliciting adverse gastrointestinal symptoms.

Methods

Faecal bacterial populations (total anaerobes, total aerobes, enterobacteria, bifidobacteria and lactobacilli), faecal pH and faecal short chain fatty acids (SCFA) were studied in a randomized longitudinal study of 75 non-adapted healthy adults before and after consumption of low doses of lactitol. Subjects consumed 25 g tablets of milk chocolate containing 10 g sweetener as sucrose:lactitol in ratios of 10:0, 5:5 or 0:10 daily for 7 d.

Results

No significant changes in faecal bacterial counts occurred in the 10:0 or 5:5 sucrose:lactitol groups. There were no significant changes in faecal anaerobes, aerobes, Enterobacteriaceae or lactobacilli during the study period in subjects consuming 0:10 sucrose:lactitol but there was a significant increase (P = 0.017) in bifidobacteria. There were no significant changes in faecal pH and SCFA for the 10:0 or 5:5 sucrose:lactitol groups but a significant decrease (P = 0.02) in faecal pH and significant increases (P = 0.001) in concentrations of propionic and butyric acids were observed in the 0:10 sucrose:lactitol group. There were few adverse symptoms of gastrointestinal intolerance to the daily consumption of 10 g lactitol.

Conclusions

The results show that low doses of lactitol can beneficially affect the faecal flora without eliciting gross symptoms of intolerance and that lactitol can be classified as a prebiotic.
Literatur
1.
Zurück zum Zitat Abrahamse SL, Pool-Zobel BL, Rechkemmer G (1999) Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat colon cells. Carcinogenesis 20:629–634CrossRef Abrahamse SL, Pool-Zobel BL, Rechkemmer G (1999) Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat colon cells. Carcinogenesis 20:629–634CrossRef
2.
Zurück zum Zitat Anon (1988) Association of the British pharmaceutical industry (ABPI). Patient information and consent for clinical trials. ABPI: London Anon (1988) Association of the British pharmaceutical industry (ABPI). Patient information and consent for clinical trials. ABPI: London
3.
Zurück zum Zitat Arunachalam KD (1999) Role of Bifidobacteria in nutrition, medicine and technology. Nutr Res 19:1559–1597CrossRef Arunachalam KD (1999) Role of Bifidobacteria in nutrition, medicine and technology. Nutr Res 19:1559–1597CrossRef
4.
Zurück zum Zitat Ballongue J, Schumann C, Quignon P (1997) Effects of lactulose and lactitol on colonic microflora and enzymic activities. Scand J Gastroenterol 222:S41–S44 Ballongue J, Schumann C, Quignon P (1997) Effects of lactulose and lactitol on colonic microflora and enzymic activities. Scand J Gastroenterol 222:S41–S44
5.
Zurück zum Zitat Beaugerie L, Flourié B, Pellier P, Achour L, Franchisseur C, Rambaud JC (1991) Tolérance clinique, absorption intestinale et valeur énergétique de quatre polyols pris à jeun (clinical tolerance, intestinal absorption, and energy value of four sugar alcohols). Gastroenterol Clin Biol 15:929–932 Beaugerie L, Flourié B, Pellier P, Achour L, Franchisseur C, Rambaud JC (1991) Tolérance clinique, absorption intestinale et valeur énergétique de quatre polyols pris à jeun (clinical tolerance, intestinal absorption, and energy value of four sugar alcohols). Gastroenterol Clin Biol 15:929–932
6.
Zurück zum Zitat Cummings JH (1983) Fermentation in human large intestine; evidence and implications for health. Lancet 1:1206–1208CrossRef Cummings JH (1983) Fermentation in human large intestine; evidence and implications for health. Lancet 1:1206–1208CrossRef
7.
Zurück zum Zitat Cummings JH, Gibson GR, Macfarlane GT (1989) Quantitative estimates of fermentation in the hindgut of man. Acta Vet Scand 86:S76–S82 Cummings JH, Gibson GR, Macfarlane GT (1989) Quantitative estimates of fermentation in the hindgut of man. Acta Vet Scand 86:S76–S82
8.
Zurück zum Zitat Cummings JH, Macfarlane GT (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70:443–459 Cummings JH, Macfarlane GT (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70:443–459
9.
Zurück zum Zitat Cummings JH, Macfarlane GT, Englyst HN (2001) Prebiotic digestion and fermentation. Am J Clin Nutr 72:S415–S420 Cummings JH, Macfarlane GT, Englyst HN (2001) Prebiotic digestion and fermentation. Am J Clin Nutr 72:S415–S420
10.
Zurück zum Zitat Gibson GR, Fuller R (1998) The role of probiotics and prebiotics in the functional food concept. In: Sadler MJ, Saltmarsh M (eds) Functional foods: the consumer, the products and the evidence. The Royal Society of Chemistry, London, pp 3–14 Gibson GR, Fuller R (1998) The role of probiotics and prebiotics in the functional food concept. In: Sadler MJ, Saltmarsh M (eds) Functional foods: the consumer, the products and the evidence. The Royal Society of Chemistry, London, pp 3–14
11.
Zurück zum Zitat Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concepts of prebiotics. J Nutr 125:1401–1412 Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concepts of prebiotics. J Nutr 125:1401–1412
12.
Zurück zum Zitat Goovaerts L, Ravelli GP (1993) Lactitol monohydrate for the treatment of chronic constipation-a multicentre study of the efficacy and tolerability of an individually adjusted daily dose. Acta Therapeut 19:61–71 Goovaerts L, Ravelli GP (1993) Lactitol monohydrate for the treatment of chronic constipation-a multicentre study of the efficacy and tolerability of an individually adjusted daily dose. Acta Therapeut 19:61–71
13.
Zurück zum Zitat Grimble GK, Patil DH, Silk DB (1988) Assimilation of lactitol, an ‘unabsorbed’ disaccharide in the normal human colon. Gut 29:1666–1671 Grimble GK, Patil DH, Silk DB (1988) Assimilation of lactitol, an ‘unabsorbed’ disaccharide in the normal human colon. Gut 29:1666–1671
14.
Zurück zum Zitat Hartemink R, Domenech VR, Rombouts FM (1997) LAMVAB-A new selective medium for the isolation of lactobacilli from faeces. J Microbiol Meth 29:77–84CrossRef Hartemink R, Domenech VR, Rombouts FM (1997) LAMVAB-A new selective medium for the isolation of lactobacilli from faeces. J Microbiol Meth 29:77–84CrossRef
15.
Zurück zum Zitat Hartemink R, Kok BJ, Weenk GH, Rombouts FM (1996) Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. J Microbiol Meth 27:33–43CrossRef Hartemink R, Kok BJ, Weenk GH, Rombouts FM (1996) Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. J Microbiol Meth 27:33–43CrossRef
16.
Zurück zum Zitat Kearsley MW, Dziedzic SZ, Birch GG, Smith PD (1980) The production and properties of glucose syrups 2. Sweetness of glucose syrups and related carbohydrates. Starke 32:244–247CrossRef Kearsley MW, Dziedzic SZ, Birch GG, Smith PD (1980) The production and properties of glucose syrups 2. Sweetness of glucose syrups and related carbohydrates. Starke 32:244–247CrossRef
17.
Zurück zum Zitat Koutsou GA, Storey DM, Lee A, Zumbe A, Flourie B, LeBot Y, Olivier P (1996) Dose related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate. Eur J Clin Nutr 50:17–21 Koutsou GA, Storey DM, Lee A, Zumbe A, Flourie B, LeBot Y, Olivier P (1996) Dose related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate. Eur J Clin Nutr 50:17–21
18.
Zurück zum Zitat Lanthier PL, Morgan MY (1985) Lactitol in the treatment of chronic hepatic encephalopathy; an open comparison with lactulose. Gut 26:415–420 Lanthier PL, Morgan MY (1985) Lactitol in the treatment of chronic hepatic encephalopathy; an open comparison with lactulose. Gut 26:415–420
19.
Zurück zum Zitat Liu Q, Duan ZP, Ha DK, Benqmark S, Kurtivic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39:1441–1449CrossRef Liu Q, Duan ZP, Ha DK, Benqmark S, Kurtivic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39:1441–1449CrossRef
20.
Zurück zum Zitat Livesey G (2001) Tolerance of low-digestible carbohydrates: a general view. Br J Nutr 85:S7–S16CrossRef Livesey G (2001) Tolerance of low-digestible carbohydrates: a general view. Br J Nutr 85:S7–S16CrossRef
21.
Zurück zum Zitat Macfarlane GT, Cummings JH (1991) The colonic flora, fermentation and large bowel digestive function. In: Philips SF, Pemberton JH, Shorter RG (eds) The large intestine: physiology, pathophysiology and disease. Raven Press Ltd, New York, pp 51–92 Macfarlane GT, Cummings JH (1991) The colonic flora, fermentation and large bowel digestive function. In: Philips SF, Pemberton JH, Shorter RG (eds) The large intestine: physiology, pathophysiology and disease. Raven Press Ltd, New York, pp 51–92
22.
Zurück zum Zitat Macfarlane GT, Cummings JH (1999) Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ 318:999–1003 Macfarlane GT, Cummings JH (1999) Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ 318:999–1003
23.
Zurück zum Zitat Macfarlane GT, Gibson GR (1995) Microbiological aspects of the production of short-chain fatty acids in the large bowel. In: Cummings JH, Rombeau JL, Sakata T (eds), Physiological and clinical aspects of short-chain fatty acids. Cambridge University Press, Cambridge pp 87–105 Macfarlane GT, Gibson GR (1995) Microbiological aspects of the production of short-chain fatty acids in the large bowel. In: Cummings JH, Rombeau JL, Sakata T (eds), Physiological and clinical aspects of short-chain fatty acids. Cambridge University Press, Cambridge pp 87–105
24.
Zurück zum Zitat Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R (2001) Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterol 120:71–78CrossRef Mandal M, Olson DJ, Sharma T, Vadlamudi RK, Kumar R (2001) Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterol 120:71–78CrossRef
25.
Zurück zum Zitat Marteau P, Flourie B (2001) Tolerance to low-digestible carbohydrates: symptomatology and methods. Br J Nutr 85:S17–S21 Marteau P, Flourie B (2001) Tolerance to low-digestible carbohydrates: symptomatology and methods. Br J Nutr 85:S17–S21
26.
Zurück zum Zitat Marteau P, Pochart P, Flourie B, Pellier P, Santos L, Desjeux JF, Rambaud JC (1990) Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora of humans. Am J Clin Nutr 52:685–888 Marteau P, Pochart P, Flourie B, Pellier P, Santos L, Desjeux JF, Rambaud JC (1990) Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora of humans. Am J Clin Nutr 52:685–888
27.
Zurück zum Zitat Minekus M, Smeets-Peeters M, Bernalier A, Marol-Bonnin S, Havenaar R, Marteau P, Alric M, Fonty G, Huis in’t Veld JHJ (1999) A computer controlled system to stimulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 53:108–114CrossRef Minekus M, Smeets-Peeters M, Bernalier A, Marol-Bonnin S, Havenaar R, Marteau P, Alric M, Fonty G, Huis in’t Veld JHJ (1999) A computer controlled system to stimulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 53:108–114CrossRef
28.
Zurück zum Zitat Modler HW (1994) Bifidogenic factors- sources, metabolism and applications. Int Dairy J 4:383–407CrossRef Modler HW (1994) Bifidogenic factors- sources, metabolism and applications. Int Dairy J 4:383–407CrossRef
29.
Zurück zum Zitat Patil DH, Grimble GK, Silk DBA (1987) Lactitol, a new hydrogenated lactose derivative—intestinal absorption and laxative threshold in normal human subjects. Br J Nutr 57:195–199CrossRef Patil DH, Grimble GK, Silk DBA (1987) Lactitol, a new hydrogenated lactose derivative—intestinal absorption and laxative threshold in normal human subjects. Br J Nutr 57:195–199CrossRef
30.
Zurück zum Zitat Pryde SE, Duncan SH, Hold GH, Stewart CS, Flint HJ (2002) The microbiology of butyrate fermentation in the human colon. FEMS Microbiol Lett 217:133–139CrossRef Pryde SE, Duncan SH, Hold GH, Stewart CS, Flint HJ (2002) The microbiology of butyrate fermentation in the human colon. FEMS Microbiol Lett 217:133–139CrossRef
31.
Zurück zum Zitat Rambaud JC, Flourie B (1994) Mechanisms of carbohydrate induced diarrhoea. In: Binder HJ, Cummings JH, Soergel K (eds) Short chain fatty acids. Kluwer Academic Press, pp 232–239 Rambaud JC, Flourie B (1994) Mechanisms of carbohydrate induced diarrhoea. In: Binder HJ, Cummings JH, Soergel K (eds) Short chain fatty acids. Kluwer Academic Press, pp 232–239
32.
Zurück zum Zitat Ravelli GP, Whyte A, Spencer R, Hotten P, Harbron C, Keenan R (1995) Effect of lactitol intake upon stool parameters and the faecal bacterial flora in chronically constipated women. Acta Ther 21:243–255 Ravelli GP, Whyte A, Spencer R, Hotten P, Harbron C, Keenan R (1995) Effect of lactitol intake upon stool parameters and the faecal bacterial flora in chronically constipated women. Acta Ther 21:243–255
33.
Zurück zum Zitat Roberfroid MB (2001) Prebiotics: preferential substrates for specific germs? Am J Clin Nutr 73:S406–S409 Roberfroid MB (2001) Prebiotics: preferential substrates for specific germs? Am J Clin Nutr 73:S406–S409
34.
Zurück zum Zitat Sakata T (1987) Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors. Br J Nutr 58:95–103CrossRef Sakata T (1987) Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors. Br J Nutr 58:95–103CrossRef
35.
Zurück zum Zitat Scevola D, Bottari A, Franchini A, Guanziroli A, Faggi A, Monzillo V, Pervesi L, Oberto L (1993) The role of lactitol in the regulation of the intestinal microflora in liver disease. Giorn Ital Malatt Infett Parassit 45:906–918 Scevola D, Bottari A, Franchini A, Guanziroli A, Faggi A, Monzillo V, Pervesi L, Oberto L (1993) The role of lactitol in the regulation of the intestinal microflora in liver disease. Giorn Ital Malatt Infett Parassit 45:906–918
36.
Zurück zum Zitat Scheppach W, Bartram HP, Richter F (1995) Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 31A:1077–1080CrossRef Scheppach W, Bartram HP, Richter F (1995) Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 31A:1077–1080CrossRef
37.
Zurück zum Zitat Scheppach W, Luehrs H, Menzel T (2001) Beneficial health effects of low digestible carbohydrate consumption. Br J Nutr 85:S23–S30CrossRef Scheppach W, Luehrs H, Menzel T (2001) Beneficial health effects of low digestible carbohydrate consumption. Br J Nutr 85:S23–S30CrossRef
38.
Zurück zum Zitat Suau A, Bonnet R, Sutren M, Godon J-J, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807 Suau A, Bonnet R, Sutren M, Godon J-J, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807
39.
Zurück zum Zitat Tarao K, Tamai S, Ito Y, Okawa S, Hayashi M (1995) Effects of lactitol on faecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy. Japan J Gastroenterol 92:1037–1050 Tarao K, Tamai S, Ito Y, Okawa S, Hayashi M (1995) Effects of lactitol on faecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy. Japan J Gastroenterol 92:1037–1050
40.
Zurück zum Zitat Vanderdonckt J, Coulon J, Denys W, Ravelli GP (1990) Study of the laxative effect of lactitol (Importal®) in the elderly institutionalized, but not bedridden, population suffering from chronic constipation. J Clin Exp Gerontol 12:171–189 Vanderdonckt J, Coulon J, Denys W, Ravelli GP (1990) Study of the laxative effect of lactitol (Importal®) in the elderly institutionalized, but not bedridden, population suffering from chronic constipation. J Clin Exp Gerontol 12:171–189
41.
Zurück zum Zitat Wang X, Gibson GR (1993) Effects of the in vitro fermentation of oligofructose and insulin by bacteria growing in the human large intestine. J Appl Bacteriol 75:373–380 Wang X, Gibson GR (1993) Effects of the in vitro fermentation of oligofructose and insulin by bacteria growing in the human large intestine. J Appl Bacteriol 75:373–380
42.
Zurück zum Zitat Wilson KH, Blitchington RB (1996) Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62:2273–2278 Wilson KH, Blitchington RB (1996) Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62:2273–2278
43.
Zurück zum Zitat Wollowski I, Rechkemmer G, Pool-Zobel BL (2001) Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73:451–455 Wollowski I, Rechkemmer G, Pool-Zobel BL (2001) Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73:451–455
44.
Zurück zum Zitat Yanahira S, Morita M, Aoe S, Suguri T, Nakajima I, Deya E (1995) Effects of lactitol-oligosaccharide on the intestinal microflora in rats. J Nutr Sci Vitaminol (Tokyo) 41:83–94 Yanahira S, Morita M, Aoe S, Suguri T, Nakajima I, Deya E (1995) Effects of lactitol-oligosaccharide on the intestinal microflora in rats. J Nutr Sci Vitaminol (Tokyo) 41:83–94
Metadaten
Titel
Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology
verfasst von
Michelle Finney
Joanne Smullen
Howard A. Foster
Saskia Brokx
Prof. David M. Storey
Publikationsdatum
01.09.2007
Verlag
D. Steinkopff-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 6/2007
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-007-0666-7

Weitere Artikel der Ausgabe 6/2007

European Journal of Nutrition 6/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.